These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15711658)

  • 1. Male breast disorders in Jordan. Disease patterns and management problems.
    Yaghan RJ; Bani-Hani KE
    Saudi Med J; 2004 Dec; 25(12):1877-83. PubMed ID: 15711658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The male breast carcinoma: a center experience].
    Ludwig S; Hauss JP; Hohlfeld S; Hildebrandt G; Horn LC; Leinung S
    Zentralbl Chir; 2007 Oct; 132(5):386-90. PubMed ID: 17907079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of male breast carcinoma].
    Zhou Z; Shao Y; Zhao D
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):235-6. PubMed ID: 10921019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer of the male breast].
    Sciacca P; Benini B; Marinelli C; Borrello M; Massi G
    Minerva Chir; 2000 May; 55(5):307-12. PubMed ID: 10953564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nipple discharge cytology in the diagnosis of breast disease: a study of 1948 nipple discharge smears from 1530 patients.
    Gupta RK; Gaskell D; Dowle CS; Simpson JS; King BR; Naran S; Lallu S; Fauck R
    Cytopathology; 2004 Dec; 15(6):326-30. PubMed ID: 15606366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer of the male breast.
    Sandler B; Carman C; Perry RR
    Am Surg; 1994 Nov; 60(11):816-20. PubMed ID: 7978672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
    Babiera GV; Rao R; Feng L; Meric-Bernstam F; Kuerer HM; Singletary SE; Hunt KK; Ross MI; Gwyn KM; Feig BW; Ames FC; Hortobagyi GN
    Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thirty-year experience of surgery for breast carcinoma in men.
    de Perrot M; Deléaval J; Robert J; Spiliopoulos A
    Eur J Surg; 2000 Dec; 166(12):929-31. PubMed ID: 11152252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male breast cancer: a retrospective study from a regional cancer center in northern India.
    Shukla NK; Seenu V; Goel AK; Raina V; Rath GK; Singh R; Kriplani AK; Deo SV; Misra MC
    J Surg Oncol; 1996 Feb; 61(2):143-8. PubMed ID: 8606547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative radiotherapy of the chest wall in patients with male breast cancer].
    Zabel-du Bois A; Milker-Zabel S; Wannenmacher M; Debus J
    Zentralbl Chir; 2007 Oct; 132(5):391-5. PubMed ID: 17907080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifteen cases of male breast carcinoma treated between 1980 and 1995.
    Ulutin C; Güden M; Sürenkök S; Pak Y
    Radiat Med; 1998; 16(5):383-6. PubMed ID: 9862164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous bilateral breast cancer in an aged male patient.
    Yaman E; Ozturk B; Coskun U; Buyukberber S; Kaya AO; Yildiz R; Benekli M
    Onkologie; 2010; 33(5):255-8. PubMed ID: 20502060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Three men with breast cancer].
    Bergs EA; Tanis PJ; Steller EP
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):534-7. PubMed ID: 15782690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral male breast masses: cancer risk and their evaluation and management.
    Volpe CM; Raffetto JD; Collure DW; Hoover EL; Doerr RJ
    Am Surg; 1999 Mar; 65(3):250-3. PubMed ID: 10075303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobular breast cancer in men: case report and review of the literature.
    Mariolis-Sapsakos T; Theodoropoulos G; Flessas II; Orfanos F; Orfanos N; Konstantinou EA; Zagouri F; Vlachodimitropoulos D; Zografos GC
    Onkologie; 2010; 33(12):698-700. PubMed ID: 21124042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carcinoma of the male breast. Prognostic factors and outcome of surgical treatment].
    Tocchi A; Mazzoni G; Lepre L; Liotta G; Miccini M; Bettelli E; Cassini D; Agostini N; Costa G
    G Chir; 2002; 23(8-9):325-9. PubMed ID: 12564307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.